SDD, HME, nanocrystal/particle
The depth of our bioavailability enhancement offering makes us a leader in addressing drug solubility and dissolution rate issues.
Particle engineering through micronization or spray drying
This expertise in particle engineering has been utilized in creating a full-service offering for dry powder inhaler (DPI) formulations.
Lipid multiparticulates, coated beads, mini-tablets and tastemasking
Multiparticulates (MP) allow the administered drug dose to be delivered as multiple discrete units each carrying a fraction of the dose. They can be easily swallowed, can better distribute the dose in the body and can be incorporated into many dosage forms
Experts in our field
David Lyon, Ph.D.
David Lyon currently serves as a Sr. Fellow, Global R&D, advising internal and external collaborations in bioavailability enhancement, inhalation, modified release, and bioprocessing. He received his B.S. in Chemistry from Western Washington University and Ph.D. in Inorganic Chemistry from the University of Oregon. Following a Post-Doctoral stint at the California Institute of Technology, David joined Bend Research as a Research Chemist in 1991. During his tenure at Bend Research, he held positions of increasing responsibility, culminating in the role of Senior Vice President of Research prior to the company’s acquisition by Capsugel and, subsequently, Lonza.
Sustainability